Frazier Lifesciences Acquisition Corporation Unit
FLACU
FLACU was delisted on the 22nd of November, 2022.
21 hedge funds and large institutions have $35.8M invested in Frazier Lifesciences Acquisition Corporation Unit in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
9% less funds holding
Funds holding: 23 → 21 (-2)
10% less capital invested
Capital invested by funds: $39.9M → $35.8M (-$4.09M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.56M |
| 2 |
SIM
Sandia Investment Management
Boston,
Massachusetts
|
+$297K |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$24.2K |
| 4 |
Walleye Capital
New York
|
+$5.02K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$14.9M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.95M |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$1.2M |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$9.91K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$9K |
FLACU Hedge Fund Activity: Q1 2022 in Review
21 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q1 2022, worth a combined $35.8M — down 10% from $39.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FLACU and 4 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $1.56M. The largest seller was Frazier Management, exiting entirely with an estimated $14.9M sold.
- 21 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q1 2022, down from 23 in Q4 2021.
- Funds reported $35.8M of Frazier Lifesciences Acquisition Corporation Unit stock for Q1 2022, down 10% quarter-over-quarter.
- 4 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q1 2022 and 6 closed out, a net change of -2 holders.
- The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q1 2022 was Wolverine Asset Management, an estimated $1.56M added.
- The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q1 2022 was Frazier Management, an estimated $14.9M sold.
Based on aggregated 13F filings for Q1 2022.